Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
BRAVETTI v. LIU et al
Case Number:
3:12-cv-07492
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
April 29, 2015
Chinese Pharma Co. Derivative Suit Premature, Judge Rules
A New Jersey federal judge on Tuesday dismissed a derivative suit brought against the leadership of American Oriental Bioengineering Inc. for allegedly lying to shareholders about the company's financial status, saying the plaintiff did not satisfy pre-suit requirements showing the board wrongfully refused to take action.
-
December 11, 2013
Pharma Co. Investors Can Serve China Execs Via US Counsel
A New Jersey federal judge on Wednesday said that shareholders bringing a derivative action against the leadership of American Oriental Bioengineering Inc. can serve the company's China-based officers and directors through their U.S.-based counsel.